advertisement

Benign and Malignant Skin Leisions

50 %
50 %
advertisement
Information about Benign and Malignant Skin Leisions
Health & Medicine

Published on March 11, 2014

Author: mahmoodi2000

Source: slideshare.net

advertisement

Skin Tumors Seyed Morteza Mahmoodi

Skin • Weight - 16% TBW • Surf. Area - 2sq.m • Thickness - 0.5-4mm • Layers -Epidermis - Basement membrane -Dermis - Subcutaneous Layer

Composition of skin

Epidermis o Thickness - 0.07-12 mm o Stratified sq. epithelium o Different layers Stratum corneum (Stratum lucidum) Stratum granulosum Stratum spinosum Stratum basale

Cells of the Epidermis  Melanocytes  basal layer protect against UV irradiation  Racial differences are due to variation in melanin production, not melanocyte numbers  Merkel cells sensation  Langerhans’ cells  Dendritic cells  Antigen-presenting cells

Dermis  Thickness - 0.6-3mm  2 layers papillary reticular  Skin appendages  Blood vessels  Nerve endings  Cells: Mast cells and Histiocytes

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Skin tags  Syringoma  Others

Seborrheic Keratosis  One of the most common benign tumors of the skin  Often confused with malignancies  Seborrheic keratoses unusual before age 30  Most people develop at least one seborrheic keratosis in their lifetime  Seborrheic keratoses are cosmetically bothersome, but may also be subject to irritation and traumatization,

Seborrheic Keratosis

Clinical Findings  Typically multiple  Most often seen on the trunk  The size and surface appearance of the lesions vary considerably  Most are 2 mm to 2.0 cm, although larger lesions are common  Lesions may be flat or raised  The surface may be smooth, velvety, or verrucous.

Color and structure  The color of lesions is extremely variable,  Lesions tend to be sharply demarcated, oval, and often oriented along skin cleavage lines  Most have a “stuck-on” appearance and waxy texture. The surface tends to crumble when picked.  Raised or pedunculated seborrheic keratoses may be indistinguishable from skin tags and compound melanocytic nevi.

Irritated seborrheic keratosis  When inflamed, SKs become slightly swollen and develop an irregular, red flare in the surrounding skin.  Itching and erythema can then appear spontaneously in other SKs that have not been manipulated and in areas without SKs.  With continued inflammation, the SK loses most of its normal characteristics and becomes a bright red, oozing mass with a friable surface that itches intensely and resembles an advanced melanoma or a pyogenic granuloma.

Seborrheic keratosis vs. Melanoma  SKs can show many of the features of a malignant melanoma, including an irregular border and variable pigmentation.  The key differential diagnostic features are the surface characteristics.  Melanomas have a smooth surface that varies in elevation and in color, density, and shade.  SKs preserve a uniform appearance over their entire surface.  Many SKs occur in sun-exposed areas.

Clinical variants Dermatosis papulosa nigra Stucco keratoses

Treatment  Cryosurgery is effective for flat to minimally raised lesions  Thicker lesions are best removed by cautery and curettage under local anesthesia.  Hypopigmentation or hyperpigmentation are possible side effects  Residual scarring is minimal. Applying gentle pressure to the surrounding skin often provides enough tension to allow for easy curettage of lesions.

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Coetaneous tags  Syringoma

Moles  Moles (melanocytic naevi) as they are due to a proliferation of melanocytes  Moles may be flat or protruding. They vary in colour from pink to dark brown or black.  The number of moles a person has depends on genetic factors and on sun exposure.  Melanocytic naevi may be present at birth (congenital) but more usually begin to grow during childhood although new ones can appear at any age, sometimes in crops

Variants  Junctional naevi  compound naevi  Intradermal naevi  Cellular naevi.  Blue naevi  Moles may darken following sun exposure or during pregnancy.  During adulthood they often lose their pigmentation, and they may even disappear in old age.

Risk of melanoma  Malignant melanoma sometimes develops within congenital melanocytic naevi.  The risk in a small or medium-sized mole is under 1%  Melanoma is more likely in the giant naevi (perhaps about 5% over a lifetime) especially in those that lie across the spine; the cancer can start in the skin or within the central nervous system. It is then very difficult to detect and treat.

Removal of moles  Although most moles are harmless and can be safely left alone, moles may be treated under the following conditions:  Possible malignancy: a mole that has bled, has an unusual shape, is growing rapidly or changing colour.  Nuisance moles: a mole that is irritated by clothing, comb or razor.  Cosmetic reasons: the mole is unsightly.

Removal  Shave biopsy  scalpel or by electrosurgery. The wound heals to leave a flat white mark, but sometimes the colour remains the same as the original mole.  Excision biopsy  if the mole is a flat one or melanoma is suspected

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Coetaneous tags  Syringoma

Dermatofibroma  Dermatofibroma is a common, benign, dermal papule.  The etiology is unknown.  Pontaneous benign neoplastic process Vs. reactive hyperplasia in response to injury or bite  These lesions occur more often in women  Most are asymptomatic, but itching and tenderness may occur occasionally

Clinical findings  Dermatofibromas discrete firm dermal papules, 3- 7 mm in diameter.  Most are dome shaped  Dermatofibromas typically flesh colored to pink with a poorly defined rim of tan to brown pigmentation  Larger ( >3cm) lesions can be worrisome and may require a biopsy for definitive diagnosis  Dermatofibromas should be stable in size, appearance, and color.  If they are not, they should be biopsied to confirm their benign nature.

Dermatofibroma Palpation  The lesion is fixed within the skin, but movable over the underlying subcutaneous fat. On palpation, the lesion feels like a firm button. Pinching a dome-shaped dermatofibroma between two fingers causes the lesion to retract and dimple below the level of surrounding skin. Pigmented variant  Rarely, lesions may be blue to black in color as a result of hemosiderin deposition, which may resemble melanoma. The surface may be smooth and shiny to scaly or excoriated. Location/Region  Although dermatofibromas may arise on any cutaneous surface, most are found randomly distributed on the extremities. Lesions are usually solitary, however, multiple lesions are not uncommon. Rarely, dermatofibromas occur on the palms or the soles. Dermatofibromas should be stable in size, appearance, and color

Treatment  Dermatofibromas are benign skin tumors that do not require treatment unless they are symptomatic, repeatedly traumatized, or cosmetically bothersome.  Surgical excision with primary closure is the treatment of choice for symptomatic lesions.  If incompletely excised, the patient should be warned of possible recurrence.

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Pilar cyst  Keratoacanthoma  Epidermal cyst  Coetaneous tags  Syringoma  Others

Pilar Cyst  A pilar cyst is a firm, subcutaneous, keratin-filled cyst originating from the outer root sheath of the hair follicle.  Roughly 90% of pilar cysts are found on the scalp, with the remaining 10% occurring on the face, neck, back, and scrotum.  The epithelium of the outer root sheath undergoes a different form of keratinization than cutaneous epithelium.

Clinical findings  The surface is smooth and dome-shaped.  Pilar cysts may be difficult to distinguish from epidermal cysts clinically, except by location.  Both present as a firm, subcutaneous nodules ranging from 0.5 to 5.0 cm.  No central punctum is seen over a pilar cyst, as is found over an epidermal cyst.  When dissected, a pilar cyst possesses a tough, white-gray wall that is more resistant to tearing than the wall of an epidermal cyst.  The pilar cyst wall separates easily and cleanly from the surrounding dermis.  If a pilar cyst ruptures, the area becomes inflamed, red, and tender and boggy on palpation.

Clinical findings  Pilar cysts almost always develop after puberty.  The tendency to develop pilar cysts often has an autosomal dominant inheritance.  Pilar cysts are multiple in 70% of patients who have them.  Pilar cysts persist indefinitely and slowly grow to a stable size unless they rupture.  Pilar cysts rupture less frequently than epidermal cysts, presumably because the pilar cyst possesses a thicker wall.  Rupture usually results from an external trauma.  A brisk foreign body inflammatory reaction follows and can be quite painful and resembles a furuncle.

Clinical findings pilar cyst  Large cysts may be cosmetically objectionable.  Some cysts are so large and tender, they may interfere with wearing hats and helmets.  Acute inflammation after rupture is often misdiagnosed as infection.  Antibiotics are of little value in such cases.  Incision and drainage under local anesthesia improve comfort and limit scarring.  Elective excision before rupture prevents

Treatment  Pilar cysts are easily removed with excision under local anesthesia.  An incision is made over the cyst, exposing the cyst’s glossy white external surface.  The cyst wall is freed easily from the surrounding connective tissue by blunt dissection.  At this stage, smaller cysts may be expressed intact up through the incision by steady, firm pressure on each side of the incision.  The incised cyst wall is clamped, and through a combination of gentle traction and pressure on each side of the incision, the now smaller, partially emptied cyst is delivered through the incision.  Larger cysts, which cannot be expressed in this manner, should be incised and their contents removed by curettage.  Sutures may be needed to close the incision site.

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Pilar cyst  Keratoacanthoma  Epidermal cyst  Cutaneous tags  Syringoma  Others

Keratoacanthoma Description  Keratoacanthoma is a rapidly growing crateriform nodule with a distinctive clinical appearance that is best regarded as a low-grade squamous cell carcinoma. The peak incidence of keratoacanthoma is between ages 50 and 70. This tumor is rare before 40 years of age. Caucasians with fair complexions are most often affected. Epidemiology  Chemical exposure and human papillomavirus have been implicated as a cause in animal models, although their role in humans is controversial. Historically, keratoacanthomas have been regarded as benign regressing lesions, however, they should be thought of as variants of squamous cell carcinoma and treated as s

Clinical findings common features  A keratoacanthoma is a characteristic solitary flesh-colored to red, crateriform nodule, usually 0.5 to 2.0 cm in diameter.  The lesion erupts rapidly and is often quite tender.  A central keratotic plug or depression conceals a deep keratinous cavity.  This plug or depression gives the nodule its characteristic volcano-like shape.  The nodule is firm in texture, tender to palpation and pressure.  Keratoacanthoma nearly always appears on sun- damaged skin.  Typical locations include the face, neck, dorsal hands and sun exposed extremities.  It occurs on the legs more often in women.

Keratoacanthoma Clinical findings :

Growth phases ka  Three growth phases are described:  1. Proliferative phase: a solitary papule appears suddenly and then rapidly grows to its maximum size over 2 to 4 weeks.  2. Mature phase: the lesion is stable in size and appearance for weeks to months; it may appear crateriform if the core has been partially removed.  3. Resolving phase: the base becomes indurated, the central core is expelled, and the base resorbs, leaving a pitted scar. This phase may last several months.

Treatment Topical 5-FU Mechanical debridement Cryotherapy Curettege & Electrodesiccation Dermabrasion Surgical excision

Ka Treatment  It is best to presume a diagnosis of squamous cell carcinoma pending biopsy results and clinical follow-up.  An excisional biopsy or shave removal should be performed.  It is important to biopsy deep enough to evaluate the dermis for possible invasion.  Treatment options include complete excision with margins and electrodesiccation and curettage.  Any of these options are curative in the vast majority of cases.

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Skin tags  Syringoma  Others

Epidermal Cyst  Description  An epidermal cyst is a firm, subcutaneous, keratin-filled cyst originating from true epidermis, most often from the hair follicle infundibulum.  Epidermal cysts are common, usually solitary, and arise spontaneously.  They occur most commonly on the trunk, postauricular fold and on the posterior neck.

Potential to rupture  Cysts frequently develop in areas of friction.  Most epidermal cysts arise from the squamous epithelium of the hair follicle.  Unlike pilar cysts, the epidermal cyst wall is fairly delicate and thus prone to rupture.  Rupture is followed by foreign body reaction to keratin extruded into the dermis and acute inflammation.  Such lesions appear to be infected. However, cultures are usually sterile.

Typical findings/characteristic findings  Epidermal cysts are firm, dome-shaped, pale yellow, cystic nodules ranging in size from 0.5 to 5.0 cm in size.  Cysts are somewhat mobile but are tethered to the overlying skin through a small punctum that often appears as a comedo.  This punctum represents the follicle from which the cyst developed.  These cysts may be flat or flush to the surface of the skin or elevated well above the surface. In either case, they are easily palpable.

Excision  Epidermal cysts that have not previously ruptured can be excised easily and completely under local anesthesia. Epidermal cysts on the face may rupture and lead to scarring.  Cosmetic considerations of elective surgical excision must be weighed against scar formation resulting from rupture.  Such lesions are far more difficult to remove once they have ruptured.  Recurrent epidermal cysts that have previously ruptured and scarred are best excised along with the surrounding scar once the inflammation has subsided.  Asymptomatic epidermal cysts occurring elsewhere do not require treatment.

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Skin tags  Syringoma  Others

Skin Tags  Description  Skin tags or achrocordons, are common, benign, fleshy papules occurring in the skin folds.  They are uncommon before age 30 and common thereafter.  Skin tags are more common in overweight persons. Roughly 25% of adults have at least one skin tag.  The majority of patients with skin tags have only a few such lesions.  There may be a familial tendency toward multiple skin tags.  Undisturbed lesions are usually asymptomatic.  Skin tags may become irritated by friction, jewelry or clothing.  They may become tender and may bleed, when traumatized, twisted, torn, or thrombosed.

Clinical findings  Skin tags are skin-colored or slightly pigmented, 1 to 5 mm pedunculated papules.  They are typically not difficult to diagnose.  They may be flat or filiform, although most are soft, fleshy, and pedunculated on a thin stalk.  The axillae are the most common location to find skin tags.  Skin tags also occur on the neck, eyelids, as well as in other intertriginous areas such as the inframammary and inguinal creases.  The overwhelming majority of skin tags are benign and have no internal disease association.

Treatment  Asymptomatic skin tags do not require treatment.  Patients often request removal for bleeding, tenderness or for cosmetic reasons.  Skin tags are best treated by scissor excision with or without local anesthesia.  Electrocautery and cryosurgery can also be used.  Many dermatologists feel that histologic confirmation is usually not necessary, but submission of all skin tags for histologic review is a topic of debate

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Skin tags  Syringoma  Others

Syringoma Description  Syringomas are the most common tumor of the intraepidermal eccrine sweat glands.  These appendage tumors develop after puberty and increase in number throughout young adulthood.  Lesions are asymptomatic, stable in size and appearance, and persistent.  The autosomal dominant inheritance of multiple syringomas is well established.  Syringomas occur with increased frequency in individuals with Down syndrome or trisomy 21.

Clinical Findings  Syringomas are small, skin-colored to yellow, 1- to 2-mm papules.  They are most commonly found on the lower eyelids.  They also occur on the malar cheeks, axillae, upper chest, abdomen, umbilicus, and vulva.  Papules are usually symmetrically distributed and asymptomatic.  Syringomas persist indefinitely and remain small.  They have no potential for malignancy.  They may resemble flat warts or sebaceous hyperplasia.  Facial lesions are of cosmetic concern, and most patients request removal of larger lesions.  The patient may be concerned that the lesions are cancerous.  Women seeking evaluation of vulvar lesions may

Treatment  Syringomas may be removed for cosmetic purposes.  Electrodesiccation and curettage, laser surgery, and trichloroacetic acid may be used with variable success.  Sharp dissection or scissor excision of lesions is easily performed under local anesthesia.  All of these procedures can lead to scarring, so care and precision are warranted.  In some patients, syringomas are too numerous to remove all lesions completely.

Benign Tumors  Seborrheic Keratosis  Melanocytic neavi  Dermatofibroma  Keratoacanthoma  Pilar cyst  Epidermal cyst  Coetaneous tags  Syringoma  Others

Pyogenic granuloma  Pyogenic granulomas are a benign overgrowth of blood vessels. They present as rapidly growing pinkish red nodules which are friable and readily bleed. They may follow trauma and are often found on the fingers and lips. They are best excised to exclude an amelanotic malignant melanoma.

Cherry angioma  Campbell de Morgan spots  These are benign angiokeratomas that appear as tiny pinpoint red papules, especially on the trunk, and increase with age. No treatment is required.

Swellings arising from the skin Benign Tumors  Benign Papillomata  Sebaceous cyst  Strawberry nevus  Histiocytoma

Premalignant Lesion Leukoplakia Actinic Keratosis Radiation Keratosis Tar Keratosis Arsenical Keratosis Bowens disease  Erythroplakia of Queyrat Pagets disease

Leucoplakia  Etiology : Smoking, Syphilis, Sepsis, Sharp edge of the tooth, Spirits, Spices --- the 6 S  Incidence: Occurs in 40 – 70 yrs of age with male dominance

Histopathology  Gross feature: White hyperkeratotic patch in the mucosa  Histology : hyperkeratosis over a thickened acanthotic but orderly mucosal epithelium.

Leukoplakia  White plaques  Etiology * age = 40-70 yrs * sex = males * habits = tobacco ,alcohol ,use of chronic irritants * inf. = HPV-16 * others = ill fitting dentures

 Clinical findings :

Actinic or solar keratosis  Etiology : Sun exposure (U.V) and hydrocarbons contact  Incidence : in persons past middle life  Prognosis : SCC may develop

Actinic Keratosis Etiology • Synonyms - solar keratosis, senile keratosis • Age = >40 • Sex = male • Occupation = outdoor works • Race = fair skinned, blue eyes • Genetics = xeroderma pigmentosum

Histopathology  Gross feature: White hyperkeratotic patch in the mucosa  Histology : hyperkeratosis over a thickened acanthotic but orderly mucosal epithelium.

Histopathology  Gross feature: Lesions are less than 1 cm in diameter; are tan brown, red or skin colored; and have a rough, sandpaper like consistency.  Multiple lesions on the face and the backs of hands  Histology : Building up of excess keratin, cytological atypia and associated basal cell hyperplasia

 Clinical findings:

Prevention  recreational exposure  Sunscreen & protective clothing

Radio dermatitis  Early: erythema, which goes onto desquamation and pigmentation  Late: atrophy, irregular hyperpigmentation and telangectasis and hair loss.  SCC may eventually develop

Radiation Keratosis Etiology : Exposure to ionizing radiation

Clinical findings

Arsenical Keratosis  Clinical findings:

Tar Keratosis Synonym : Tar wart Etiology : exposure to polycyclic aromatic hydrocarbons

Clinical findings :

Bowen Disease  A.k.a. carcinoma in situ and squamous intraepidermoid neoplasia.  Etiology : Involve predominantly skin unexposed to the sun (i.e., protected). Role of HPV 16.  Incidence : Involves the genital region of both men and women above the age of 35  Prognosis : May transform into SCC

Histopathology  Gross feature : Solitary, thickened, gray- white, opaque plaque with shallow ulceration and crusting  Histology : the epidermis shows proliferation with numerous mitoses, some atypical.

Bowen’s disease Clinical findings:

Erythroplasia of Queyrat  Etiology : Role of HPV 16  Incidence : Men, usually above age of 25yrs  Prognosis : Has a potential to develop into invasive carcinoma

Histopathology  Gross feature : Appears on the glans penis and prepuce as single or multiple shiny red, velvety plaques.  It may at times produce a discharge and become painful.

Erythroplasia of Queyrat  Bowen’s disease of the penis  Clinical features :

Management  Excision biopsy  Curettage  Electrodessicatio n  Cryotherapy  Protection  5 fluorouracil cream  Dermabrasion  CO2 laser vaporization.  Photodynamic therapy (for Bowen Disease)

Cutaneous Horn Synonym – cornu cutaneum Clinical finding :

Paget’s Disease Clinical findings:

Carcinomas  Basal cell carcinoma  SCC  Malignant melanoma (nodular)

BASAL CELL CARCINOMA BCC  Definition and etiology:  Basal cell carcinoma is a malignant neoplasm arising from the basal cells of the epidermis  Most basal cell carcinomas are caused by sunlight-induced damage to the skin.

BCC

Clinical features:BCC  Basal cell carcinoma is the most frequent malignancy in the United States,  with more than 750,000 new cases reported annually. Although basal cell carcinoma almost never metastasizes, its malignant nature is emphasized by the local destruction that it can cause. As with other sun-induced neoplasms of the skin, fair-complected  individuals and those with a lot of sunlight exposure are most likely to develop basal cell carcinoma.

Clinical features BCC  Clinically, there are four major types of basal cell carcinomas: nodular,  superficial, morpheaform, and pigmented.  Rarer types include cystic and keratotic carcinoma and fibroepithelioma of Pinkus.  They are, of course, found most commonly on sun-exposed skin.  Nodular basal cell carcinomas, the most common type, appears  as a pearly semitranslucent papule or nodule that has a depressed center,  telangiectasia, and rolled waxy border. Crusting and ulceration frequently occur.  The most common location is on the face, particularly the nose. Superficial basal cell carcinomas look quite different.  They are red, slightly scaling, slightly crusted, well-demarcated  eczematous-appearing patches that most commonly occur on the trunk.  Infiltrative or morpheaform basal cell carcinoma appears as an atrophic, whitish, scarlike eroded or crusted plaque.  Pigmented basal cell carcinoma is a shiny brown, blue, or black papule or nodule.

DD BCC The differential diagnosis  of basal cell carcinoma depends on the type.  For nodular basal cell carcinoma, the differential diagnosis includes ;  Sebaceous hyperplasia, fibrous papule of the nose, nonpigmented nevus, and squamous cell  carcinoma. Dermatitis, psoriasis, and Bowen’s disease (squamous cell carcinoma in  situ) appear similar to superficial basal cell

DD BCC  Seborrhoeic keratosis,pigmented nevus, and, most important, malignant melanoma must be ruled out in the case of pigmented basal cell carcinoma.  For crusted nonhealing scarlike lesions, the differential diagnosis is mainly between basal cell and squamous cell carcinoma.  A skin biopsy, either shave, punch, or excision, should be accomplished to confirm the diagnosis of basal cell carcinoma.  The tumor is composed of a thickened epidermis with invasive buds and lobules of basaloid cells.

BCC Treatment:  Curettage and electrodesiccation of the lesion or excision are the most common surgical modalities used to treat basal cell carcinoma.  Because of the locally destructive nature and potential for recurrence of the disease, treatment should be done by an experienced clinician who can individualize the therapeutic modality  based on location of the lesion, histopathologic type, size of the basal cell carcinoma, and its primary or recurrent status.  Less commonly used treatments are radiation therapy, cryosurgery, and topical chemotherapy.  A specialized surgical technique, Mohs’ surgery, is indicated for recurrent basal cell carcinoma and for primary tumors with a high risk of recurrence.

Basal cell carcinoma  Synonyms: basal cell epithelioma, basalioma,rodent ulcer  A malignancy arising from the epidermal basal cells.

Etiology and Pathogenesis  Genetics: chromosome 9q22.3 (PTCH)  Sunlight  Ionizing radiation: 10 Gy  Carcinogens: tar, oils and arsenic  Chronic skin damage: scars of trauma and vaccination  Other factors : immunosuppression

Epidemiology  Incidence 40- 80/10000. U.S 500,000/ year  Age =>60 years  Gender = > men  Race= less in dark skinned  Occupation= outdoor exposure  Geography = high altitudes,equator

Clinical findings  Majority in the face  Line connecting the corners of the mouth to the bottom of the ears  Lower part of the face, scalp and upper part of the trunk

Initial basal cell carcinoma  Tiny ,indurated pearly area  crusted or scabbed area  Rolled edge  Cheek and nose

Nodular basal cell carcinoma  Nodular  Pearly or waxy border  Prominent telangiectases  Central dell or ulceration D.D: intradermal melanocytic nevus, squamous cell carcinoma, giant

Ulcerated basal cell carcinoma  Synonyms:Ulcus rodens,rodent ulcer  Large ,destructive  Ragged border  Nasolabial fold,medial canthus and about the ear  Crusts and granulation tissues D.D: factitial ulcers

Pigemented basal cell carcinoma  Blacks,Hispanics, Native Americans, Orientals  Papular or nodular  Slate-blue to black D.D:melanocytic nevus, blue nevus, malignant melanoma, vascular lesions(angiokerato

Cicatricial basal cell carcinoma  Synonym; morpheaform basal cell carcinoma  Yellow and white waxy plaques  Ill defined edge  Enlarging scar  Nose, forehead  Mimic keloid  Clinically aggressive

Cystic basal cell carcinoma  Soft translucent papule  Marked telangiectasia  eyes D.D hidrocystoma, adnexal tumors

Superficial basal cell carcinoma  Synonyms: multicentric, pagetoid, eczematoid  Superficial,multiple  Pink or brown scaly plaque  Whip cord edge  >10cm  Tumor buds

Fibroepithelioma,Metatypical, BCC in scars  Fibroepithelioma= soft pink flesh coloured or pale coloured nodules on the trunk  Metatypical= cannot differentiate b/w BCC and SCC under the microscope  BCC in scars= ulcer not a telangiectatic nodule. Recurrent BCC and a scar

Metastatic BCC  0.0028 to 0.1%  Metatypical BCC  Large ulcerated basal cell carcinomas in the mid face  Elderly  immunocompromised

histopathology

Histopathology

Therapy  size  Location  Subtype

 Excision  Micrographic surgery  Cyrotherapy  Curettage and electrodesiccation  Radiation therapy

Course and prognosis  Slow relentless growth destroys tissue locally  Untreated invades bone, cartilage  Usually 95% cure rate

SQUAMOUS CELL CARCINOMA  Definition and etiology:  Squamous cell carcinoma is a malignant neoplasm of keratinocytes that is locally  invasive and has the potential to metastasize.  Ultraviolet radiation, x-rays, papillomavirus infection, and chemical carcinogens such as soot and arsenic cause squamous cell carcinoma.

Clinical features SCC  Squamous cell carcinoma is the second most common skin cancer in the United States, with more than 100,000 new cases diagnosed annually.  As with other sunlight-induced skin cancers, the frequency of squamous cell carcinoma is increased in those who are fair complected or engage in many outdoor activities.  The history of a bleeding growth or ulcer should arouse suspicion of squamous cell carcinoma.  Squamous cell carcinoma most often arises in sun-damaged skin.  It also develops on the mucous membranes and in areas of chronic injury such as burn scars, chronic radiodermatitic lesions, chronic draining sinuses, and areas of erosive discoid lupus erythematosus.

SCC  The examination reveals a hard papule or nodule that is erythematous to flesh- colored, smooth, scaling, and crusted.  Squamous cell carcinoma in situ(Bowen’s disease) has a different appearance, being a well-demarcated, slightly scaling, slightly crusted, eczematous-appearing patch.

DD SCC  The differential diagnosis of squamous cell carcinoma includes  keratoacanthoma, hypertrophic actinic keratosis, wart, basal cell carcinoma, and seborrheic keratosis. Any lesion that is crusted or ulcerated should be suspected of being squamous cell carcinoma, and biopsy must be done.  This reveals a hyperkeratotic thickened epidermis containing atypical keratinocytes that invade the dermis.

Treatment SCC Squamous cell carcinoma should be totally excised.  Follow-up to monitor for local recurrence as well as metastases is required.  The squamous cell carcinomas most likely to metastasize are those that are large or histologically poorly differentiated, have deep invasion, or occur in damaged skin or the mucous membranes of the lips, glans penis, and vulva.  Metastasis is generally to the regional lymph nodes, and careful attention should be given to examining them for lymphadenopathy.

Squamous cell carcinoma  Primary cutaneous SCC is a malignant neoplasm of keratinising epidermal cells

Epidemiology  30-60/100000  Basal: squamous =5:1 to 10:1  Age=>40 years  Sex= men  Occupation= outdoor workers  Genetics = xeroderma pigmentosum  Geography= equator or high altitudes

Etiology and pathogenesis  Irradiation: UV,PUVA,Heat  Chronic degenerative and inflammatory process  Chemical carcinogenesis:petroleum, tobacco  Oncogenic Viruses: HPV  Genetic disorders: xeroderma pigmentosum, Ferguson-Smith  Immunosuppression  Personal habits: alcohol and tobacco

Clinical findings  indistinct clinical picture  Hard exophytic,inflamed nodule  vermiottes  Ulcerated and necrotic  more destructive  Metastases Unfavourable signs: rapid growth,induration, bleeding

Histopathology

Histopathology

Differential Dx:  Adnexal tumors  Amelanotic malignant melanoma  Seborrheic keratosis  Nodular,indurated, ulcerated lesion

Course  Sun exposed and actinic keratoses =less metastases  >2cm  >4mm depth  Poorly differentiated  immunosuppresed }}More likely toMore likely to metastasizemetastasize

Prognosis  Location  Size  Thickness  Degree of differentiation  5 year survival <20-25% if regional nodes are involved

Therapy  Excision  Cyrotherapy  Curettage and electrodesiccation  Radiation Therapy  Sentinal lymph node dissection

Marjolin’s ulcer  A squamous cell carcinoma which develops in a chronic scar such as along standing ulcer or osteomyelitis sinus.  Slow growth – relatively avascular  Painless  Absence of secondary deposits in regional lymph nodes

Extent of the tumor Prognosis Management Malignant Melanoma

Level I Clark Level V Level IV Level III Level II

Breslow 0.75 mm 0.76-1.5 mm 1.51-3.0 mm >3.0 mm

Skin grafts STSG epidermis + part of dermis FTSG whole thickness of the skin excised

SGT

Add a comment

Related presentations

Related pages

Dermatology Associates of San Antonio Benign and Malignant ...

Dermatology Associates of San Antonio is ... cysts and growths whether they are benign or malignant. What is a benign lesion? ... A Benign skin lesion is ...
Read more

Common Benign Skin Tumors - American Family Physician

Common Benign Skin Tumors FREE ... The ability to properly diagnose and treat common benign tumors and to distinguish them from malignant lesions is a ...
Read more

Benign Skin Lesions: Overview of Benign Skin Lesions ...

Initially, benign lesions must be differentiated from malignant lesions. This is best done by being familiar with characteristics of common ...
Read more

Benign and Malignant Skin Lesions - Surgical Associates

Benign and Malignant Skin Lesions. More than 1 million people are expected to develop skin cancer this year, according to the National Cancer Institute.
Read more

Cutaneous lesions: benign and malignant. - National Center ...

Cutaneous lesions: benign and malignant. ... and recommended treatment for several benign and malignant lesions that may arise on the ... Skin Neoplasms ...
Read more

BENIGN AND MALIGNANT SKIN LESIONS IN RENAL TRANSPLANT ...

Methods: One hundred patients (53 men and 47 women) were consecutively examined for benign and malignant skin complications since transplantation in Razi ...
Read more

Overview of benign lesions of the skin - UpToDate

Overview of benign lesions of the skin. Authors Beth G Goldstein, MD. ... but are insufficient to drive benign or malignant skin tumors. Cell Cycle 2014; ...
Read more

BENIGN AND MALIGNANT SKIN LESIONS - Home (World Scientific)

Benign and Malignant Skin Lesions 103 b1289 Essentials of Plastic Surgery • Junctional: pale to dark brown, flat, smooth, round macules, appear between ...
Read more

Benign/Malignant Skin Lesions, Cysts and Soft Tissue ...

Skin cancer is the uncontrolled overproduction of skin cells. This type of cancer can be present in all different colors, shapes and sizes. There are three ...
Read more